NYSE:VNRX
Volitionrx Ltd.
Volitionrx Ltd.'s revenue grew 40.0% in fiscal 2025 to $1.7M while operating margin rose to −1258.5%, its highest in 7 years. Free cash flow was −$19.8M, −1144.7% of revenue, and the diluted share count rose 23.5%.Summary generated from Volitionrx Ltd.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.7M
Revenue growth+40.0%
Revenue, 5-yr CAGR+164.1%
Gross marginn/a
Operating margin−1258.5%
Net margin−1352.2%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$19.8M
FCF margin−1144.7%
Share count change+23.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 | 1 | 2 |
| Operating income | −28 | −32 | −36 | −27 | −22 |
| Net income | −27 | −31 | −36 | −27 | −23 |
| Free cash flow | −22 | −17 | −19 | −26 | −20 |
Recent filings
- 4Insider transaction report
Sep 30, 2026 - 4Insider transaction report
Sep 30, 2026 - 8-KCurrent report
Sep 25, 2026 - 8-KCurrent report
Sep 15, 2026 - 8-KOther events
Sep 14, 2026 - 8-KEntry into a material agreement
Sep 2, 2026 - 8-KCurrent report
Sep 2, 2026 - 8-KCurrent report
Aug 24, 2026